Stripping Down the Mitochondrial Cholesterol Hydroxylase System, a Kinetics Study
The origin of steroid hormones in mammals is cholesterol that is metabolized by the mitochondrial CYP11A1 system. The cytochrome P450 is fed with reduction equivalents via a small electron transfer chain consisting of NADPH, adrenodoxin reductase, and adrenodoxin. Though the redox behavior of the in...
Gespeichert in:
Veröffentlicht in: | The Journal of biological chemistry 2004-08, Vol.279 (33), p.34269-34276 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The origin of steroid hormones in mammals is cholesterol that is metabolized by the mitochondrial CYP11A1 system. The cytochrome
P450 is fed with reduction equivalents via a small electron transfer chain consisting of NADPH, adrenodoxin reductase, and
adrenodoxin. Though the redox behavior of the individual protein components has been studied previously, the kinetics of the
system in its entirety has not yet been analyzed. In this study we combine surface plasmon resonance experiments to determine
the binding constants for the different pairs of redox partners with measurements of the pre-steady-state kinetics of the
different reaction steps of this system and steady-state kinetics. We could correlate the individual protein-protein interactions
with the effect of distinct reduction-oxidation steps on the overall catalytic activity of the CYP11A1 system. For the first
time, we were able to follow the reduction of each of the protein components of this system within one measurement when we
mixed all oxidized protein components with NADPH. These measurements allowed the determination of the individual apparent
rate constants for the reduction of all three proteins involved. In addition, variation of the ionic strength in these experiments
revealed different optimum salt concentrations for the reduction of adrenodoxin reductase and adrenodoxin, respectively, and
unraveled dramatically changing reduction rates of CYP11A1 by adrenodoxin. |
---|---|
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1074/jbc.M402798200 |